NCT02077751View on ClinicalTrials.gov

BioRBC Survival in Adults With Prior Antibody Response to BioRBCs

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2019

Study Completion Date

December 31, 2019

Conditions
Anemia
Interventions
DRUG

biotin labelled RBCs

Autologous red blood cells are biotin labelled and transfused to the subject. Survival of these red blood cells is tracked through examination of blood samples until no biotin labelled red blood cells remain.

Trial Locations (1)

52242

University of Iowa, Iowa City

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

John A Widness

OTHER

NCT02077751 - BioRBC Survival in Adults With Prior Antibody Response to BioRBCs | Biotech Hunter | Biotech Hunter